Cordis Recalls FLEXSTENT Stent Systems Due to Pouch Integrity Issues
Cordis is recalling 784 FLEXSTENT stent systems because holes or tears can form in the protective pouches, potentially compromising the device.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the defect involves a risk-of-harm product (medical device) where injury has not yet been reported, fitting the High severity criteria.
Plain-English summary
Cordis Corporation is recalling 784 units of the FLEXSTENT Femoropopliteal Self-Expanding Stent System. The recall is due to a defect where holes and/or tears can be introduced in the FLEXSTENT inner pouch under some conditions, and to a lesser degree, in the outer pouch.
The FLEXSTENT system is indicated for the treatment of atherosclerotic de novo native superficial femoral artery lesions and proximal popliteal lesions. The affected units were distributed worldwide, including nationwide in the United States and in the Czech Republic, Italy, the Netherlands, and New Zealand. The recall covers 28 specific catalog numbers ranging from CAC-50030-V2 to CAC-80150-V2.
This is an FDA Class II recall. The source text does not report any specific injuries or illnesses associated with this defect. Healthcare providers and patients should contact Cordis Corporation for further instructions on how to handle the affected devices.
The recalled product
- Product
- FLEXSTENT Femoropopliteal Self-Expanding Stent System. Product Usage: The FSS FLEXSTENT¿ Femoropopliteal SES clinical product is indicated for treatment of atherosclerotic de novo native superficial femoral artery lesions and proximal popliteal lesions.
- Manufacturer
- Cordis Corporation
- Category
- Medical Device — Vascular Stent
- Affected units
- 784
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- 28 Catalog Numbers CAC-50030-V2
- CAC-60030-V2
- CAC-70030-V2
- CAC-80030-V2
- CAC-50040-V2
- CAC-60040-V2
- CAC-70040-V2
- CAC-80040-V2
- CAC-50060-V2
- CAC-60060-V2
- CAC-70060-V2
- CAC-80060-V2
- CAC-50080-V2
- CAC-60080-V2
- CAC-70080-V2
- CAC-80080-V2
- CAC-50100-V2
- CAC-60100-V2
- CAC-70100-V2
- CAC-80100-V2
Distribution
Part of a larger recall action
This product is one of 5 recalled by Cordis Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Cordis Corporation
See all →- HighSMART FLEX Biliary Stent System Recalled for Potential Distal Tip Dislodgement
FDA (Devices) · 2021-11-24
- HighSMART FLEX 6x120 Biliary Stent System Recalled for Potential Distal Tip Dislodgement
FDA (Devices) · 2021-11-24
- HighCordis SMART FLEX Biliary Stent System recalled for potential tip separation
FDA (Devices) · 2021-11-24
- HighCordis SMART FLEX Biliary Stent System Recalled for Distal Tip Separation
FDA (Devices) · 2021-11-24
- HighSMART FLEX Biliary Stent System Recalled Due to Potential Tip Dislodgement
FDA (Devices) · 2021-11-24
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12